Stephen W. Kidder’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,545
| Closed | -$585K | – | 75 |
|
|
2025
Q3 | $585K | Sell |
10,545
-18,760
| -64% | -$1.1M | 0.17% | 55 |
|
|
2025
Q2 | $2.02M | Buy |
29,305
+12,130
| +71% | +$825K | 0.61% | 34 |
|
|
2025
Q1 | $1.19M | Buy |
17,175
+14,635
| +576% | +$1.21M | 0.37% | 38 |
|
|
2024
Q4 | $218K | Sell |
2,540
-100
| -4% | -$10.8K | 0.07% | 67 |
|
|
2024
Q3 | $314K | Sell |
2,640
-310
| -11% | -$41.3K | 0.09% | 56 |
|
|
2024
Q2 | $421K | Sell |
2,950
-120
| -4% | -$15.9K | 0.13% | 56 |
|
|
2024
Q1 | $394K | Hold |
3,070
| – | – | 0.13% | 58 |
|
|
2023
Q4 | $318K | Sell |
3,070
-110
| -3% | -$10.9K | 0.1% | 59 |
|
|
2023
Q3 | $289K | Sell |
3,180
-120
| -4% | -$10.6K | 0.1% | 66 |
|
|
2023
Q2 | $267K | Sell |
3,300
-200
| -6% | -$16.3K | 0.09% | 69 |
|
|
2023
Q1 | $278K | Buy |
3,500
+50
| +1% | +$3.55K | 0.1% | 65 |
|
|
2022
Q4 | $233K | Sell |
3,450
-700
| -17% | -$41K | 0.09% | 70 |
|
|
2022
Q3 | $207K | Sell |
4,150
-150
| -3% | -$8.04K | 0.08% | 67 |
|
|
2022
Q2 | $240K | Sell |
4,300
-100
| -2% | -$5.55K | 0.09% | 67 |
|
|
2022
Q1 | $244K | Buy |
+4,400
| New | +$226K | 0.08% | 72 |
|
|
2021
Q4 | – | Sell |
-4,300
| Closed | -$206K | – | 73 |
|
|
2021
Q3 | $206K | Buy |
+4,300
| New | +$208K | 0.06% | 74 |
|
|
2018
Q1 | – | Sell |
-8,250
| Closed | -$221K | – | 92 |
|
|
2017
Q4 | $221K | Sell |
8,250
-1,000
| -11% | -$25.4K | 0.08% | 89 |
|
|
2017
Q3 | $223K | Sell |
9,250
-140
| -1% | -$3.16K | 0.08% | 90 |
|
|
2017
Q2 | $202K | Buy |
+9,390
| New | +$189K | 0.08% | 89 |
|
|
2016
Q4 | – | Sell |
-11,590
| Closed | -$242K | – | 98 |
|
|
2016
Q3 | $242K | Sell |
11,590
-200
| -2% | -$4.96K | 0.1% | 95 |
|
|
2016
Q2 | $317K | Sell |
11,790
-560
| -5% | -$15.4K | 0.13% | 84 |
|
|
2016
Q1 | $335K | Buy |
12,350
+830
| +7% | +$22.2K | 0.14% | 80 |
|
|
2015
Q4 | $334K | Buy |
11,520
+1,920
| +20% | +$53.1K | 0.14% | 80 |
|
|
2015
Q3 | $261K | Hold |
9,600
| – | – | 0.13% | 81 |
|
|
2015
Q2 | $263K | Hold |
9,600
| – | – | 0.12% | 86 |
|
|
2015
Q1 | $256K | Hold |
9,600
| – | – | 0.11% | 91 |
|
|
2014
Q4 | $202K | Sell |
9,600
-400
| -4% | -$8.94K | 0.09% | 95 |
|
|
2014
Q3 | $239K | Sell |
10,000
-400
| -4% | -$9.21K | 0.11% | 91 |
|
|
2014
Q2 | $240K | Sell |
10,400
-300
| -3% | -$6.62K | 0.16% | 57 |
|
|
2014
Q1 | $244K | Sell |
10,700
-500
| -4% | -$10.7K | 0.16% | 57 |
|
|
2013
Q4 | $207K | Sell |
11,200
-1,000
| -8% | -$17.4K | 0.14% | 60 |
|
|
2013
Q3 | $206K | Sell |
12,200
-1,320
| -10% | -$22.2K | 0.16% | 60 |
|
|
2013
Q2 | $210K | Buy |
+13,520
| New | +$225K | 0.17% | 66 |
|
Other funds holding NVO
F
Stephen W. Kidder's NVO Position: Q4 2025 in Review
Stephen W. Kidder sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 10,545 shares — an estimated $585K sold.
Stephen W. Kidder first reported a position in NVO in Q2 2013 and held it in 33 quarters. The position peaked at $2.02M in Q2 2025. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.
- Stephen W. Kidder reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
- Stephen W. Kidder sold 10,545 Novo Nordisk shares in Q4 2025, an estimated $585K.
- Stephen W. Kidder first reported a position in Novo Nordisk in Q2 2013 and held it in 33 quarters.
- Stephen W. Kidder's Novo Nordisk position peaked at $2.02M in Q2 2025.
- 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.
Based on Stephen W. Kidder's 13F filing for Q4 2025, filed 17 Feb 2026.